T

Tiziana Life Sciences Ltd

TLSA

1.07000
USD
0.05
(4.90%)
Market Closed
Volume
1,701
EPS
0
Div Yield
0
P/E
-6
Market Cap
95,423,380
Related Instruments
F
-0.120
(-1.11%)
10.700 USD
F
FUBO
-0.09000
(-6.12%)
1.38000 USD
GM
-0.960
(-2.17%)
43.360 USD
N
NIO
-0.38000
(-8.54%)
4.07000 USD
P
PLUG
-0.16000
(-6.48%)
2.31000 USD
R
RIDE
-0.02030
(-2.74%)
0.72000 USD
W
WKHS
-0.11000
(-7.59%)
1.34000 USD
X
XPEV
-0.44000
(-5.45%)
7.63000 USD
News

Title: Tiziana Life Sciences Ltd

Sector: Healthcare
Industry: Biotechnology
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.